# To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

> **NCT00517673** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 68 (actual)

## Conditions studied

- Healthy Subjects
- Infections, Bacterial

## Interventions

- **DRUG:** GSK945237
- **DRUG:** Sugar Pill

## Key facts

- **NCT ID:** NCT00517673
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517673, "To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00517673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*